A 6-Day Losing Streak Has Revvity Stock Down 8.0%
Today’s big story: Anthropic IPO: Priced For 2031, Or 2036?
Shares of Revvity (RVTY) have closed lower in each of the last 6 sessions, a cumulative decline of 8.0%. That erased about $1.4 billion from the company’s market value, which now stands at about $16.5 billion. The stock closed at $147.79 on Tuesday, November 17, 10.9% below its 52-week high of $165.78 and 79.9% above its low of $82.17.

How The Streak Stacks Up Against The S&P 500
Returns for RVTY and the S&P 500 over the streak and the periods around it, all ending Tuesday, November 17 and including dividends:
| Return Period | RVTY | S&P 500 |
|---|---|---|
| 1 Day | -0.7% | -1.0% |
| 6 Days (Current Streak) | -8.0% | -2.7% |
| 1 Month (21 Trading Days) | -2.0% | -4.5% |
| 3 Months (63 Trading Days) | 23.8% | -4.5% |
| Year To Date | 53.1% | 8.3% |
| 1 Year (252 Trading Days) | 59.8% | 10.3% |
A Stock-Specific Slide, Or A Market Move?
Over the same 6 trading days, the S&P 500 returned -2.7% including dividends, so the slide is mostly Revvity’s own story rather than the market’s. 13 other S&P 500 stocks are currently on losing streaks of 6 days or longer. Over the past three months the stock is up 23.8%, a window that includes the streak; over the other 57 sessions of that window it was up 34.6%.
Is The Business As Weak As The Stock?
On the fundamentals, revenue grew 4.6% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; its operating margin is 12.6%, versus a median of 17.4%; and the stock trades at 65.1 times trailing earnings against a median of 30.7. The read is mixed.
If the drop has you weighing an entry, resist buying on price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still hold up.
Weakness In One Name Should Be Noise, Not News
For a diversified holder, a streak like this is a data point. For a concentrated one, it is a hole in the plan. The difference is never the stock; it is the portfolio built around it.
Building that portfolio is what the Trefis High Quality (HQ) Portfolio does: roughly 30 businesses with the cash generation and balance-sheet strength to absorb a bad month, selected and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Make the next streak, in either direction, someone else’s drama.